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Purpose/Objective: Techniques in radiotherapy that account for the 
effects of motion of the target tissue, have gained increasing 
importance in both research and clinical practice. Validation of these 
techniques requires robotic phantoms, which represent structure, 
physical properties and motion of a human body environment and 
allow dose measurement. Such phantom was recently developed by 
our group. It allows generation respectively reproduction of previously 
recorded patient motion in all translational degrees of freedom with 
sub-millimeter precision while featuring a realistic structural design, 
which involves the relative motion of an inside tumour with respect to 
a static environment as well as an extensive modularization of tissue 
equivalent components and dosage measurement devices. The 
objective of this work is to evaluate the applicability of the novel 
robotic phantom in clinical practice of quality insurance of 
radiotherapy and assess the phantom’s potentials. 
Materials and Methods: A solid perplex sphere, encased by a layer of 
wood was used to resemble the tissues of the target of dose 
application and the surrounding lung. Radiochromic films, placed in 
five cutting planes of the sphere, were used for dose measurements. 
The sphere was attached to a flange moving in a water environment. 
Irradiation with different field forms was applied on the robotic 
phantom, first, with its actuators blocked, then, with concurrent 
playback of respiratory motion. Dose distributions measured and 
calculated by the treatment planning system (TPS) were compared. 
Results: Application of the phantom in both medical imaging and 
radiotherapy and obtained results have proven feasible. The 
construction turned out not to cause any noticable distortions, e.g. as 
a result of the robotic components of the phantom. In static case, 
measured and calculated dose distributions were compared with 
Gamma Index criteria (3mm/3%). All evaluated films agreed with the 
calculated dose distribution with an accordance above 99%. Dose 
distributions measured with the moving phantom showed typical dose 
blurring. The system components of the robotic phantom and test 
results are depicted in the figure. 
 
  
Conclusions: Suitability of the physical properties of the robotic 
phantom, applicability in clinical practice and capability of validation 
of the process chain of radiotherapy in the presence of motion with a 
realistic setup and test scenario were successfully proven. The new 
features of the robotic phantom, e.g. the uniquely high 
customizability of both motion and structure of the human body 
replication will allow the effects of motion to be comprehensively 
investigated and techniques of motion compensation to be improved 
in the future. 
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Purpose/Objective: The increasing complexity of radiotherapy (RT) 
has motivated research into three dimensional (3D) dosimetry. In this 
study we investigate the use of 3D dosimetry with polymerizing gels 
and optical computed tomography (optical CT) as a verification tool 
for complex RT: dose painting, and target tracking. 
Materials and Methods: For the dose painting studies, two dosimeters 
were irradiated with a 7-field intensity modulated radiotherapy (IMRT) 
plan with and without dose prescription based on a hypoxia image 
dataset of a head and neck patient. In the tracking experiments, two 
dosimeters were irradiated with a volumetric modulated arc therapy 
(VMAT) plan with and without clinically measured prostate motion and 
a third with both motion and target tracking. To assess the 
performance, 3D gamma analyses were performed between measured 
and calculated stationary dose distributions. 
Results: Gamma pass-rates of 95.3 % and 97.3 % (figure 1) were 
achieved for the standard and dose-painted IMRT plans. Gamma pass-
rates of 91.4 % and 54.4 % were obtained for the stationary and 
moving dosimeter, respectively, while tracking increased the pass-
rate for the moving dosimeter to 90.4 %. 
 
 
Conclusions: This study has shown that the 3D dosimetry system can 
reproduce and thus verify complex dose distributions, also when 
influenced by motion. 
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Purpose/Objective: In dose-guided radiotherapy, delivered fluence 
may be adapted based on the actual delivered patient dose in 
previous fractions, as derived from in-room acquired cone-beam CTs 
(CBCTs) and electronic portal images (EPIs).In our institute, EPIs are 
converted into absolute portal dose images (PDIs), and compared to 
PDI predictions to assess the actual delivered 2D fluence profiles. PDI 
predictions are based on segment shapes and MUs stored in the linac 
R&V system and the fraction CBCT. Estimated actual delivered 
fluences and the CBCT might then be used to reconstruct the 
delivered 3D patient dose in a fraction. In case of intra-fraction 
anatomy changes, the CBCT may not accurately represent the patient 
anatomy for all treatment beams, yielding inaccuracies in 
reconstructed patient dose. Here we will focus on the impact of intra-
fraction motion on the accuracy of estimated fluence profiles used in 
the patient dose reconstruction.  
Materials and Methods: For 50 prostate cancer patients treated with 
5-7 IMRT fields, CBCTs and EPIs were acquired in 4-5 fractions. PDIs 
derived from EPIs were compared to predictions based on the CBCT. 
To accurately predict beam transmission, Hounsfield units from the 
planning CT-scan were mapped onto the CBCT while accounting for 
the patient’s non-rigid anatomy, using our previously published 
algorithm. Predictions also accounted for treatment couch absorption, 
using our recently published couch model. As benchmark, measured 
and predicted PDIs were also compared for an anatomical phantom, 
irradiated with the plans of 10 patients. Gamma-analyses with 3% 
global dose difference and 3 mm distance to agreement as reference 
criteria were performed. Combination of fractions was evaluated to 
enhance the accuracy of estimated delivered fluence profiles.  
Results: For the phantom, the average percentage of rejected pixels 
in PDIs was 0.8±0.7% (1SD). For the 1413 evaluated patient fields this 
increased to 1.4 ± 2.8%. The increase could partially be attributed to 
intra-fraction anatomy changes. Due to these changes, the acquired 
CBCT was not fully representative for all fields. For some fractions 
this resulted in large differences between fields in agreement 
between measured and predicted PDI. Combination of the first 2 
fractions yielded results in close agreement with the phantom 
(average percentage of rejected pixels: 0.6 ±3.4%).The agreement 
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further improved to 0.3±0.6%, 0.2±0.4%, and 0.1±0.3% by combining 3, 
4, and 5 fractions, respectively. 
Conclusions: A system was developed for high accuracy assessment of 
actual delivered IMRT fluence profiles in treatment fractions for dose-
guided radiotherapy. For prostate cancer patients, intra-fraction 
anatomy changes did sometimes result in reduced accuracy. 
Combination of measurements performed in 2 or more fractions could 
largely reduce uncertainties.  
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Purpose/Objective: To evaluate the accuracy of the Gated 
Volumetric Modulated Arc Therapy (VMAT/RA) dose delivery using 
conventional 2D planar dosimetry and advanced COMPASS 3D 
dosimetry system 
Materials and Methods: We have installed Varian Real-Time Position 
Management (RPM) Gated Technology in RapidArc (RA) enabled Clinac-
iX .The advantage of Gated RapidArc (G-RA) technology is that it 
reduces the margin of Internal Target volume (ITV). G-RA was 
delivered using the RPM which uses external markers to generate 
gate-open signals of different durations. To assure the proper dynamic 
dose delivery and MLC position of G-RA treatments, we have planned 
10RA plans for lung cases in Eclipse (V8.9TPS) which use Analytical 
Anisotropic Algorithm. Plan quality was verified using conventional 2D 
planar dosimetry and advanced Compass 3D dosimetry system. 
Advantage of COMPASS over 2D planar is it provides the clinical 
relevance of error in treatment delivery.  
IBA, COMPASS system calculates and displays the delivered 3D dose 
distribution on a patient CT data by using beam modeling, dose map 
from detector measurements (Imatrix Evolution) and dose map 
reconstruction using Collapsed Cone Convolution Algorithm. For 2D 
planar dose evaluations, verification plans were generated on IBA, 
ImatrixEvolution in a Multicube Phantom and planar dose at isocenter 
plane were exported for Omipro IMRT software for gamma analysis. In 
both cases, Imatrix is fixed while Infrared reflecting box is periodically 
moved to provide gating signal for RPM.To evaluate the accuracy of 
dose delivery, measurements were performed for different duty 
cycles (DC) 100% (without Gating), 80%, 50%, 30% & 20%, i.e., number 
of interruptions were approximately increased from 5-30 times and 
same were compared with Eclipse TPS dose. Area gamma was 
analyzed with criteria 3mm distance to agreement and 3% dose 
difference. Dynalog files were analyzed and expressed as root mean 
square(RMS)of the deviations of individual leaves during treatment 
delivery. 
Results: In conventional 2D planar dose analysis the average area 
gamma less than 1 for DC 100% , 80%, 50%, 30% & 20% were 98.4±1.6%, 
98±1.2%, 97.4±1.8%, 96.6±1.3%& 96.1±2.1% for TPS vs. G-RA 
(3mm&3%) respectively. Average deviations of error root mean square 
for all MLC positions were 0.11 ±0.01mm, 0.14±0.01mm,0.25±0.02mm, 
0.32±0.02mm & 0.46±0.03mm for 100%, 80%, 50%, 30% & 20% DC 
respectively. 3D average gamma for 10 Patients PTV and organ at risk 
from COMPASS system for different DC were shown in table 1. Average 
gamma for all structure and different duty cycle is less than 0.5  
 
Structure 
Average Gamma for Ten Patients 
100% 
(without Gating) 80% 50% 30% 20% 
Body 0.16±0.04 0.17±0.04 0.16±0.04 0.16±0.04 0.16±0.04
PTV 0.33±0.12 0.33±0.13 0.33±0.12 0.32±0.12 0.34±0.13
Lungs 0.24±0.05 0.24±0.06 0.24±0.06 0.25±0.06 0.25±0.06
Heart 0.24±0.07 0.24±0.06 0.26±0.10 0.24±0.06 0.24±0.05
 
Table-1 
 
Conclusions: Both conventional 2D planar dose analysis in phantom 
and advanced COMPASS 3D dosimetry analysis in patient anatomy 
shows that Gated VMAT dose delivery can be executed with good 
clinical dosimetric accuracy as non-gated VMAT delivery. 
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Purpose/Objective: The aim of this work was to experimentally 
determine the response of an amorphous silicon electronic portal 
imaging device (EPID) to electron beams in order to use it for quality 
assurance (QA) of modulated electron radiotherapy (MERT) delivery.  
Materials and Methods: For this work, a commercially available EPID 
was used to detect electron beams of energies ranging from 6 to 18 
MeV and shaped by a photon multileaf collimator (MLC) at a source to 
surface distance of 70 cm. On the central axis, the dose response of 
the EPID to electron beams was studied by investigating the 
fundamental dosimetric properties such as reproducibility, dose 
linearity, field size response, energy response and saturation. For the 
off-axis response of the EPID, a new method to acquire the flood-field 
(FF) for the EPID calibration was developed. For validation purposes, 
the FF-corrected EPID measurements were compared to dose profiles 
of open fields and various square and irregular MLC fields measured 
with a diode in water. Finally, in order to use the EPID for QA of MERT 
delivery, a method was developed to reconstruct EPID two-
dimensional (2D) dose distributions in a water-equivalent depth of 1.5 
cm. Comparisons were performed with film measurements for static 
and dynamic mono-energetic fields as well as for multi-energetic 
fields composed by several segments of different electron beam 
energies. 
Results: The beneficial EPID dosimetric properties already known for 
photons as reproducibility, linearity with dose and dose rate were 
found to be identical for electron beam detection. The FF calibration 
method was proven to be effective and it was shown that the EPID 
accurately reproduced the dose measured in water at 1.0 cm depth 
for 6 MeV, 1.3 cm for 9 MeV and 1.5 cm for 12, 15 and 18 MeV. The 
deviations between the output factors measured with EPID and in 
water at these depths were within ±1.2% for all the energies with a 
mean deviation of 0.1%. The average gamma pass rates (criteria: 
1.25%, 1.25 mm) for profile comparison between EPID and 
measurements in water were better than 97% for all the energies 
considered in this study. When comparing the reconstructed EPID 2D 
dose distributions at 1.5 cm depth to film measurements, the gamma 
pass rates (criteria: 2%, 2 mm) were better than 97% for all tested 
cases considered.  
Conclusions: This study demonstrates the high potential of the EPID 
for electron dosimetry, and in particular, confirms the possibility to 
use it as an efficient verification tool for MERT delivery. 
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Purpose/Objective: Specialised treatment techniques have led to the 
increased use of radiotherapy fields as small as 4 mm. Dose 
measurements of small fields in air are needed to provide parameters 
for radiotherapy beam modeling and the commissioning of treatment 
planning systems. For fields larger than 40 mm, ionisation chambers 
with conventional water equivalent miniphantoms have been used for 
the measurement of the in-air output factor, Sc. However, for small 
fields, dosimetry is complicated by both the beam characteristics and 
the dosimeter design. This study describes a reliable and convenient 
method to measure Sc, for small fields and explains the clinical 
significance of our findings. 
Materials and Methods: Measurements were performed using brass 
miniphantoms, either caps (with sidewalls) or tops (no sidewalls) of 
varying heights and widths. The performance of two unshielded diodes 
(PTW 60012 and IBA SFD), EBT2 radiochromic film and a fibre optic 
dosimeter (FOD) were compared for fields defined by SRS cones (4 mm 
to 30 mm) on a Varian Novalis linear accelerator. 
